Selected ellipticine derivatives, known to target topoisomerase II, suppress the alternative lengthening of telomere (ALT) pathway in telomerase–negative cells
Articles > Article · 2020
Authors: Sevil Zencir, Meng-Hsun Hsieh, Joel-Sean Hsu, Yavuz Ergun, Guan-Ling Chou, Tsai-Kun Li, Shu-Chun Teng, Zeki Topcu
Journal of Cancer Research and Clinical Oncology, International, WoS, 2020, vol 146, pp 1671-1676